ArticleTransplant infectious disease : an official journal of the Transplantation Society

Intermittent Letermovir Dosing in Cytomegalovirus High-Risk Liver Transplant Recipients May Facilitate Development of Cell-Mediated Immunity and Prevent Post-Prophylaxis Infection.

Hanna L Kleiboeker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.